Showing results (271-280 of 479) with videos related to

Sort By:
Pageof 48
Cells|March 29, 2023
Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver CancerPo-Shuan Huang, Ling-Yu Wang, Yi-Wen Wang, et al.
Journal of Gastroenterology and Hepatology|August 6, 2014
Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between gendersMing-Ling Chang, Chen-Ming Hsu, Jeng-Hwei Tseng, et al.
Journal of Medical Virology|June 9, 2016
Acute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapyJi-Wei Lin, Ming-Ling Chang, Chao-Wei Hsu, et al.
Scientific Reports|August 2, 2016
Resistin reinforces interferon λ-3 to eliminate hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphismsMing-Ling Chang, Kung-Hao Liang, Cheng-Lung Ku, et al.
International Journal of Molecular Sciences|September 25, 2019
Characterization of Fibrinogen as a Key Modulator in Patients with Wilson's Diseases with Functional Proteomic ToolsPei-Wen Wang, Tung-Yi Lin, Yu-Chiang Hung, et al.
Journal of Gastroenterology and Hepatology|December 9, 2016
Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: A population-based cohort studyTing-Shuo Huang, Chih-Lang Lin, Mu-Jie Lu, et al.
Journal of Medical Virology|November 30, 2006
Identification of NV-F virus DNA in hepatocellular carcinomaChau-Ting Yeh, Tse-Ching Chen, Ming-Ling Chang, et al.
Pageof 48